Overview: A Strategic Expansion in Vascular Therapy Sunnybrook-based startup Vasomune Therapeutics is broadening its collaboration with pharmaceutical giant AnGes to expand the indications for their leading drug candidate designed to treat vascular damage. The new agreement injects $4 million in funding to accelerate development, clinical milestones, and regulatory progress as the two companies pursue improved…